Stocks with call strike movement; ACHN MNKD Achillion (ACHN) September 9 call option implied volatility decreased 9% to 121, MannKind (MNKD) November 12 call option implied volatility increased 2% to 89 according to IVolatility.
MannKind's Afrezza lags behind in inhaled insulin market, The Street reports The number of prescriptions written for MannKind's (MNKD) Afrezza is lagging behind in the diabetes market, reports The Street. This comes five months after Sanofi (SNY) launched the product. Afrezza is also under-performing Exubera, the first inhaled insulin launched by Pfizer (PFE) nine years ago. Reference Link